Clinical Trial Update: Nebivolol ANOCA Treatment Randomized Trial [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial evaluating Nebivolol for angina with non-obstructive coronary arteries (ANOCA) and coronary microvascular dysfunction is currently no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina with Nonobstructive Coronary Arteries
• Coronary Microvascular Dysfunction

Drugs mentioned

• Nebivolol (Nebivolol)

Snippet

Sponsor: Spanish Society of Cardiology | Conditions: ANOCA - Angina With Non-obstructive Coronary Arteries, Coronary Microvascular Dysfunction (CMD) | Phase 3 | Status: NOT_YET_RECRUITING